Fundación Universitaria de Ciencias de la Salud Report issue

Foundation Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01746641
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

fundacion universitaria de ciencias de la salud | Fundacion universitaria de ciencias de la salud | Fundacion Universitaria de Ciencias de la Salud | Fundación Universitaria de Ciencias de la Salud

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Coronavirus Infections (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8